Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer.

Matthews, Bayley G; Bowden, Nikola A; Wong-Brown, Michelle W

Matthews, Bayley G; Bowden, Nikola A; Wong-Brown, Michelle W.

Affiliation

Matthews BG; Centre for Drug Repurposing and Medicines Research, University of Newcastle, Newcastle, NSW 2289, Australia.
Bowden NA; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW 2289, Australia.
Wong-Brown MW; Hunter Medical Research Institute, Newcastle, NSW 2289, Australia.

Cancers (Basel) ; 13(23)2021 Nov 29.

Article in En | MEDLINE | ID: mdl-34885103

Key words

DNA methylation; DNA methyltransferase inhibitors; chemoresistance; epigenetic modifications; high-grade serous ovarian cancer; histone acetylation; histone deacetylase inhibitors; microRNA

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: Australia